What are they? Lipid nanoparticles (LNPs) are a crucial component in the delivery of RNA drugs, including mRNA-based therapeutics and small interfering RNA (siRNA) molecules.
What is it? mRNA delivery by viral vectors is a promising approach in the field of gene therapy and vaccine development. Viral vectors are modified
What is it? It is unavoidable for patients to have no other substances in their body when being administered a treatment. Whether it is a
What is it? An anti-drug antibody, ADA, is an antibody that binds to the therapeutic drug. They are formed as an immune response when a
Therapeutic oligonucleotides are important for altering targeted RNA pathways through a variety of mechanisms, making them a versatile tool in drug development. Understanding their ADME
As scientists, doctors and researchers race to develop vaccines and therapeutics for SARS-CoV-2, several drugs have emerged as promising candidates. Oligonucleotide therapeutics are one such
What are they? Lipid nanoparticles (LNPs) are a crucial component in the delivery of RNA drugs, including mRNA-based therapeutics and small interfering RNA (siRNA) molecules.
What is it? mRNA delivery by viral vectors is a promising approach in the field of gene therapy and vaccine development. Viral vectors are modified
What is it? It is unavoidable for patients to have no other substances in their body when being administered a treatment. Whether it is a
What is it? An anti-drug antibody, ADA, is an antibody that binds to the therapeutic drug. They are formed as an immune response when a
Therapeutic oligonucleotides are important for altering targeted RNA pathways through a variety of mechanisms, making them a versatile tool in drug development. Understanding their ADME
As scientists, doctors and researchers race to develop vaccines and therapeutics for SARS-CoV-2, several drugs have emerged as promising candidates. Oligonucleotide therapeutics are one such
Delaware Technology Park,
3 Innovation Way,
Newark, DE 19711
"*" indicates required fields
Emails are serviced by Constant Contact. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.
